SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Cytori Therapeutics named Marc Hedrick to the position of CEO, after announcing the retirement of Christopher Calhoun from that position.
Two companies founded by genomics pioneer J. Craig Venter are expanding their real estate footprint in La Jolla, leasing additional space from BioMed Realty Trust Inc.
Sorrento Therapeutics Inc. (Nasdaq: SRNE), a maker of cancer and pain medications, has launched a new subsidiary called Ark Animal Therapeutics.
Medical Marijuana Inc., having outgrown its San Diego headquarters, is relocating to a multibuilding campus in Poway.
ATyr Pharma Inc., a company that treats diseases of the immune system, has appointed biotech veteran David Weiner as its chief medical officer.
San Diego diabetes monitor maker DexCom Inc. has received a warning letter from the Food and Drug Administration following a November 2013 inspection of the company’s building.
Mary Ann Barnes, executive director of Kaiser Permanente San Diego, is taking a new role at the health system – she’s been named regional president of Kaiser Permanente Hawaii Region.
Mary Ann Barnes, executive director of Kaiser Permanente San Diego, is headed to the tropics to take on a new role at the health system – she’s been named regional president of Kaiser Permanente Hawaii Region.
RuiYi Inc., a biotechnology company split between La Jolla and Shanghai, has received $15 million in Series B financing from existing investors to further its uncommon business model.
BIOTECH: Sirenas Exploring Oceans to Find Possible Cures
Sirenas Marine Discovery Inc. is in an enviable position — it’s actually turning away investors as it turns to the ocean’s depths as a promising source for potential new drugs.
The Gary and Mary West Health Investment Fund made a series of announcements – most notably that the assets of Sense4Baby Inc., its smartphone-based pregnancy monitoring company, have been acquired by San Antonio’s AirStrip Technologies LP.
RuiYi Inc., a biotech based both in La Jolla and Shanghai, has received $15 million in Series B financing from a group of existing investors.
Assay Depot Inc., Carlsbad’s self-dubbed “Amazon.com for scientists,” has landed $3 million in Series B funding.
San Diego-based SeniorQuote Insurance Services Inc. has completed a $1.4 million Series A round.
Newly formed Seragon Pharmaceuticals Inc. has appointed N. Anthony Coles, the former CEO and board chairman of Onyx Pharmaceuticals Inc., to its board of directors.